Jinling Pharmaceutical Co Ltd (000919) — Cash Flow Reinvestment Rate
Jinling Pharmaceutical Co Ltd (000919) has a Cash Flow Reinvestment Rate of 0.17x as of September 2025, reinvesting CN¥12.56 Million (capex CN¥12.56 Million ) from operating cash flow of CN¥74.01 Million. Explore Jinling Pharmaceutical Co Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jinling Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (1999–2024)
Historical reinvestment intensity for Jinling Pharmaceutical Co Ltd across 26 annual periods. Also explore 000919 total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Jinling Pharmaceutical Co Ltd (1999–2024)
Year-by-year capital reinvestment analysis for Jinling Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Jinling Pharmaceutical Co Ltd stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 4.80x | CN¥739.80 Million | CN¥154.19 Million | CN¥201.63 Million | ▲ +80.7% |
| 2023 | 2.65x | CN¥421.94 Million | CN¥158.92 Million | CN¥186.25 Million | ▲ +30.4% |
| 2022 | 2.04x | CN¥530.76 Million | CN¥260.59 Million | CN¥309.64 Million | ▲ +264.2% |
| 2021 | 0.56x | CN¥163.32 Million | CN¥292.03 Million | CN¥162.76 Million | ▼ -57.7% |
| 2020 | 1.32x | CN¥412.12 Million | CN¥311.46 Million | CN¥291.41 Million | ▲ +104.1% |
| 2019 | 0.65x | CN¥302.01 Million | CN¥465.85 Million | CN¥125.71 Million | ▲ +4.0% |
| 2018 | 0.62x | CN¥270.52 Million | CN¥433.83 Million | CN¥136.42 Million | ▲ +259.1% |
| 2017 | 0.17x | CN¥76.94 Million | CN¥443.11 Million | CN¥66.80 Million | ▼ -87.0% |
| 2016 | 1.34x | CN¥128.57 Million | CN¥96.15 Million | CN¥107.45 Million | ▲ +56.2% |
| 2015 | 0.86x | CN¥181.83 Million | CN¥212.45 Million | CN¥104.31 Million | ▲ +181.6% |
| 2014 | 0.30x | CN¥91.14 Million | CN¥299.89 Million | CN¥91.14 Million | ▼ -42.8% |
| 2013 | 0.53x | CN¥144.05 Million | CN¥271.21 Million | CN¥144.05 Million | ▼ -34.7% |
| 2012 | 0.81x | CN¥188.76 Million | CN¥232.12 Million | CN¥188.76 Million | ▲ +71.0% |
| 2011 | 0.48x | CN¥82.20 Million | CN¥172.82 Million | CN¥82.20 Million | ▼ -11.4% |
| 2010 | 0.54x | CN¥95.48 Million | CN¥177.81 Million | CN¥95.48 Million | ▲ +4.7% |
| 2009 | 0.51x | CN¥96.60 Million | CN¥188.41 Million | CN¥96.60 Million | ▲ +607.8% |
| 2008 | 0.07x | CN¥22.11 Million | CN¥305.26 Million | CN¥22.11 Million | ▼ -59.2% |
| 2007 | 0.18x | CN¥20.97 Million | CN¥118.06 Million | CN¥20.97 Million | ▲ +6.5% |
| 2006 | 0.17x | CN¥23.09 Million | CN¥138.50 Million | CN¥23.09 Million | ▼ -50.2% |
| 2005 | 0.33x | CN¥36.61 Million | CN¥109.29 Million | CN¥36.61 Million | ▼ -26.1% |
| 2004 | 0.45x | CN¥72.47 Million | CN¥159.81 Million | CN¥72.47 Million | ▲ +29.4% |
| 2003 | 0.35x | CN¥56.73 Million | CN¥161.86 Million | CN¥56.73 Million | ▼ -55.5% |
| 2002 | 0.79x | CN¥102.63 Million | CN¥130.36 Million | CN¥102.63 Million | ▼ -54.6% |
| 2001 | 1.73x | CN¥160.27 Million | CN¥92.49 Million | CN¥160.27 Million | ▲ +198.0% |
| 2000 | 0.58x | CN¥134.49 Million | CN¥231.31 Million | CN¥134.49 Million | ▼ -67.7% |
| 1999 | 1.80x | CN¥71.57 Million | CN¥39.77 Million | CN¥71.57 Million | — |